Profile
Sector:
HealthcareIndustry:
Medical Care FacilitiesCountry:
United StatesIPO:
13 February 2019Website:
http://www.imacholdings.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 20 Nov 2024 21:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
BACK Latest News
Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an entirely new precision oncology assay for breast cancer treatment decision making utilizing the Reverse Phase Protein Array (RPPA) technology through its newly established subsidiary, Ignite Proteomics LLC (“Ignite Proteomics”). This launch follows IMAC Holdings' strategic acquisition of key assets from Theralink Technologies, Inc., and is underscored by a landmark clinical case study “ Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer”, demonstrating the power of RPPA technology in precision oncology published in npj Precision Oncology, an international, peer-reviewed journal focused on precision oncology.
FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on August 21, 2024 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”), as described more fully in the Company's Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the “SEC”) on August 15, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
Golden, CO, July 11, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ: BACK) (the “Company” or “IMAC”), a leading innovator in proteomics research and technology, announced the appointment of Dr. Peter Beitsch and Dr. Matthew Schwartz to its Board of Directors, effective June 26, 2024. This strategic move underscores the Company's commitment to advancing its position in the field of proteomics and driving innovation in precision medicine.
Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn., May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the board of directors and executive team.
Penny stocks are generally defined as securities that trade for less than $5 a share. These stocks can be volatile and unpredictable, leading many investors to avoid them.
What type of business is IMAC Holdings?
IMAC Holdings, Inc. does not have significant operations. Previously, it owned and managed innovative medical advancements and care regeneration centers, and backspace clinics. The company was founded in 2000 and is headquartered in Brentwood, Tennessee.
What sector is IMAC Holdings in?
IMAC Holdings is in the Healthcare sector
What industry is IMAC Holdings in?
IMAC Holdings is in the Medical Care Facilities industry
What country is IMAC Holdings from?
IMAC Holdings is headquartered in United States
When did IMAC Holdings go public?
IMAC Holdings initial public offering (IPO) was on 13 February 2019
What is IMAC Holdings website?
https://www.imacholdings.com
Is IMAC Holdings in the S&P 500?
No, IMAC Holdings is not included in the S&P 500 index
Is IMAC Holdings in the NASDAQ 100?
No, IMAC Holdings is not included in the NASDAQ 100 index
Is IMAC Holdings in the Dow Jones?
No, IMAC Holdings is not included in the Dow Jones index
When was IMAC Holdings the previous earnings report?
No data
When does IMAC Holdings earnings report?
Next earnings report date is not announced yet